Innovative Biotech Solutions

IntelliGenome's first product, our CRISPR-TB benchtop blood assay, is a single test for all patient groups, designed to provide ultra-sensitive detection of Mycobacterium Tuberculosis (Mtb) DNA from nucleic acids in plasma or serum to diagnose all manifestations of pulmonary tuberculosis (PTB) and extra-pulmonary tuberculosis (EPTB) disease accurately, rapidly and affordably. 

IntelliGenome's CRISPR-TB benchtop blood assay is a high-throughput diagnostic system designed for use  in CLIA labs by trained personnel.  IntelliGenome's highly sensitive diagnostic platform rapidly identifies species-specific TB cell-free DNA (cfDNA) sequences directly from blood samples, circumventing the difficulties associated with collecting sputum samples from vulnerable populations such as the very young, elderly, and seriously ill.